Skip to main content

CORRECTION article

Front. Immunol.
Sec. Microbial Immunology
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1365827

Corrigendum: Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides?

José M. Pérez de la Lastra1* Uttpal Anand2* Sergio González Acosta1 Manuel R. Lo´pez1 Abhijit Dey3 Elza Bontempi4 Antonio M. delaNuez1
  • 1Biotechnology of Macromolecules, Instituto de Productos Naturales y Agrobiolog´ıa, IPNA (CSIC), San Cristo´bal de la Laguna, Spain, Spain
  • 2Ben-Gurion University of the Negev, Israel
  • 3Department of Life Sciences, Presidency University, Kolkata, India, India
  • 4Department of Mechanical and Industrial Engineering, University of Brescia, Brescia, Italy, Italy

This article is a correction to:

Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides?
Read original article

The final, formatted version of the article will be published soon.

Receive an email when it is updated
You just subscribed to receive the final version of the article

Corrigendum on:
Pérez de la Lastra JM, Anand U, González-Acosta S, López MR, Dey A, Bontempi E and Morales delaNuez A (2022) Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides? Front. Immunol. 13:921483. doi: 10.3389/fimmu.2022.921483

Incorrect Affiliation
In the published article, there was an error in the affiliation information about Uttpal Anand [2]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel”, it should be “CytoGene Research & Development LLP, K-51, UPSIDA Industrial Area, Kursi Road (Lucknow), Dist.– Barabanki, 225001, Uttar Pradesh, India”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Conflict of Interest
Author UA was employed by the company CytoGene Research & Development LLP. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: SARS-CoV-2, antibiotic resistance, One Health approach, global health, antibiotic discovery, antimicrobial peptides, Environmental contamination, Vaccination

Received: 05 Jan 2024; Accepted: 08 Jan 2024.

Copyright: © 2024 Pérez de la Lastra, Anand, González Acosta, Lo´pez, Dey, Bontempi and delaNuez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Mx. José M. Pérez de la Lastra, Biotechnology of Macromolecules, Instituto de Productos Naturales y Agrobiolog´ıa, IPNA (CSIC), San Cristo´bal de la Laguna, Spain, San Cristo´bal de la Laguna, Spain
Mx. Uttpal Anand, Ben-Gurion University of the Negev, Be'er Sheva, Israel